Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volume kinetics of 20% albumin in conscious and anaesthetized humans with and without inflammation
2015-001135-20Phase 4Active
- Sponsor
- Södertälje sjukhus
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of albumin (human) (3 arms), sponsored by Södertälje sjukhus. Primary endpoint: Plasma volume expansion over 4 hours. Started Mar 2015; status: active.
02
Drugs
albumin (human)
Beyond the preview
Go deeper on 2015-001135-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001135-20.